Failure Analysis Of Cardiovascular Technologies Inc is categorized under Cardiographs in Delray Beach, FL and active since 2001.
Failure Analysis Of Cardiovascular Technologies Inc was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Cardiographs business, which does work in the B2B market, and is classified as a Cardiographs, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Tony Moreno at the company’s single location by writing to 3777 Gulfstream Road, Delray Beach, Florida FL 33483 or by phoning (561) 302-5745. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Failure Analysis Of Cardiovascular Technologies Inc |
| Contact Person: | Tony Moreno |
| Address: | 3777 Gulfstream Road, Delray Beach, Florida 33483 |
| Phone Number: | (561) 302-5745 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Cardiographs |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Failure Analysis Of Cardiovascular Technologies Inc was started in 2001 to provide professional Cardiographs under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Tony Moreno for inquiries that concern Failure Analysis Of Cardiovascular Technologies Inc by calling the company number (561) 302-5745, as your correspondence is most welcome. Additionally, the physical location of the single location of Failure Analysis Of Cardiovascular Technologies Inc can be found at the coordinates 26.500035,-80.054446 as well as the street address 3777 Gulfstream Road in Delray Beach, Florida 33483.
For its online presence, you may visit Failure Analysis Of Cardiovascular Technologies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.